Advisor Group Holdings, Inc. Neuro Pace Inc Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$5.9 - $10.31 $1,374 - $2,402	233 New	233 $2,000
Q1 2022 May 04, 2022	SELL	$7.06 - $11.57 $5,259 - $8,619	-745 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$15.85 - $25.07 $713 - $1,128	45 Added 6.43%	745 $12,000
Q2 2021 Aug 02, 2021	BUY	$19.03 - $26.5 $13,321 - $18,550	700 New	700 $17,000

21.3M

1.3K

100

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $230M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.